These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 26866096)
1. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS. Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096 [TBL] [Abstract][Full Text] [Related]
2. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030 [TBL] [Abstract][Full Text] [Related]
3. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch? Lee E; Redman M; Burgess G; Win N Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166 [TBL] [Abstract][Full Text] [Related]
4. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization. Dinardo CL; Bonifácio SL; Mendrone A Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242 [TBL] [Abstract][Full Text] [Related]
5. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Thakral B; Saluja K; Sharma RR; Marwaha N Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Natukunda B; Schonewille H; van de Watering L; Brand A Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889 [TBL] [Abstract][Full Text] [Related]
7. [Identification of alloantibodies and their associations: balance sheet of a year at the Auvergne-Loire French Blood Establishment]. Duboeuf S; Flourié F; Courbil R; Benamara A; Rigal E; Cognasse F; Garraud O Transfus Clin Biol; 2012 Dec; 19(6):358-65. PubMed ID: 23159062 [TBL] [Abstract][Full Text] [Related]
8. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management]. Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386 [TBL] [Abstract][Full Text] [Related]
9. Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review. Havemann H; Lichtiger B Cancer; 1992 Jan; 69(1):252-5. PubMed ID: 1727671 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy. Koelewijn JM; Vrijkotte TG; de Haas M; van der Schoot CE; Bonsel GJ BJOG; 2009 Apr; 116(5):655-64. PubMed ID: 19210505 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Pretransplant Donor-Specific Alloantibodies With Different Crossmatch Techniques. Moszkowska G; Zieliński M; Zielińska H; Dukat-Mazurek A; Dębska-Zielkowska J; Dębska-Ślizień A; Rutkowski B; Trzonkowski P Transplant Proc; 2018; 50(6):1625-1630. PubMed ID: 30056871 [TBL] [Abstract][Full Text] [Related]
12. Two-stage papain-indirect antiglobulin test and LISS direct agglutination are not appropriate for pretransfusion screening for unexpected antibodies. Pereira A; Mazzara R; Gelabert A; Castillo R Haematologica; 1991; 76(6):475-8. PubMed ID: 1820984 [TBL] [Abstract][Full Text] [Related]
13. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted? Judd WJ; Fullen DR; Steiner EA; Davenport RD; Knafl PC Transfusion; 1999 Mar; 39(3):295-9. PubMed ID: 10204593 [TBL] [Abstract][Full Text] [Related]
14. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood. Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232 [TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B; Schonewille H; Ndugwa C; Brand A Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [TBL] [Abstract][Full Text] [Related]
16. Role of enzyme-treated cells in RBC antibody screening using the gel test: a study of anti-RH1, -RH2, and -RH3 antibodies. Conne J; Schneider P; Tissot JD J Clin Lab Anal; 2007; 21(2):61-6. PubMed ID: 17385674 [TBL] [Abstract][Full Text] [Related]
17. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching. Pinkerton PH; Coovadia AS; Goldstein J Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244 [TBL] [Abstract][Full Text] [Related]